Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Esophagus Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05424432
What this trial is testing

Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of Esophagus

Who this might be right for
Locally Advanced Esophageal Carcinoma
Jiangsu Cancer Institute & Hospital 63
Large-scale testing (Phase 3)Study completedNCT02459457
What this trial is testing

A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer

Who this might be right for
Stage III Esophageal Squamous Cell Carcinoma
Fudan University 321
Early research (Phase 1)Ended earlyNCT05861947
What this trial is testing

Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

Who this might be right for
RelapseAdvanced Malignant NeoplasmNon Small Cell Lung Cancer+5 more
Aurigene Discovery Technologies Limited 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117
What this trial is testing

Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc. 329
Large-scale testing (Phase 3)UnknownNCT01054274
What this trial is testing

A Multicentric Randomized Controlled Trial of Self-Expandable Esophageal Radiation Stent

Who this might be right for
Esophageal Cancer
Southeast University, China 180
Testing effectiveness (Phase 2)Study completedNCT01522768
What this trial is testing

Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center 42
Early research (Phase 1)Looking for participantsNCT07544589
What this trial is testing

Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

Who this might be right for
Colorectal CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+1 more
Dispatch Biotherapeutics 66
Testing effectiveness (Phase 2)Ended earlyNCT00539617
What this trial is testing

Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 7
Early research (Phase 1)Looking for participantsNCT07181473
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Lung Cancer (NSCLC)Prostate CancerEsophageal Cancer+1 more
Phrontline Biopharma 200
Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Early research (Phase 1)Ended earlyNCT03144661
What this trial is testing

An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaEsophageal Cancer+3 more
Incyte Corporation 25
Early research (Phase 1)Looking for participantsNCT06010862
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerPancreas Cancer+4 more
Chongqing Precision Biotech Co., Ltd 36
Testing effectiveness (Phase 2)Study completedNCT01787006
What this trial is testing

Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
University Hospital Schleswig-Holstein 74
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Early research (Phase 1)Active Not RecruitingNCT05143970
What this trial is testing

First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic CancerMetastatic Breast CancerMetastatic Pancreatic Cancer+6 more
Institut Paoli-Calmettes 27
Testing effectiveness (Phase 2)Study completedNCT01630083
What this trial is testing

Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer

Who this might be right for
CLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of EsophagusCLDN18.2-positive Gastric Adenocarcinoma
Astellas Pharma Global Development, Inc. 252
Not applicableUnknownNCT04984096
What this trial is testing

Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Shanghai Chest Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT00177255
What this trial is testing

Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers

Who this might be right for
Cancer
University of Pittsburgh 40
Testing effectiveness (Phase 2)UnknownNCT00995358
What this trial is testing

A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Yamanashi 60
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Next Page